Taking dicyclomol transaminases decreased and then increased, may be seen in adverse drug reactions, but also in the worsening of the original disease, further impairment of liver function and other conditions. Dicyclanol is a biphenyl structural derivative, on acute liver injury, immune hepatitis aminotransferase elevation has a lowering effect, can reduce liver damage, hepatitis B virus has a partial inhibitory effect, is mainly used for the treatment of chronic hepatitis caused by aminotransferase elevation. 1. Adverse drug reactions: the common adverse reactions of dicyclomine are rash, dizziness, abdominal distension, nausea, etc. There are also a small number of people who will experience elevated serum aminotransferase and platelet drop. 2. Exacerbation of primary disease: as a hepatoprotective drug, dicyclomol can only delay liver damage, but not treat the primary disease. If the causes of liver function damage are not eliminated, such as viral hepatitis without antiviral treatment, alcoholic liver disease without alcohol cessation, non-alcoholic fatty liver disease without weight control and diet, etc., it may cause further damage to liver function, and the aminotransferase will rise again after it has been lowered. Taking dicyclomine transaminase decreased and then increased, may be seen in the adverse drug reaction or the aggravation of the primary disease, it is recommended to consult a doctor in a timely manner, by a professional doctor to assess the condition, to formulate an individualized diagnosis and treatment plan, to actively control and treat the primary disease, to protect liver function.